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Familial glomerulocystic kidney disease (GCKD) is a dominantly inherited condition characterized by glomerular
cysts and variable renal size and function; the molecular genetic etiology is unknown. Mutations in the gene encoding
hepatocyte nuclear factor (HNF)–1b have been associated with early-onset diabetes and nondiabetic renal disease—
particularly renal cystic disease. We investigated a possible role for the HNF-1b gene in four unrelated GCKD
families and identified mutations in two families: a nonsense mutation in exon 1 (E101X) and a frameshift mutation
in exon 2 (P159fsdelT). The family members with HNF-1b gene mutations had hypoplastic GCKD and early-onset
diabetes or impaired glucose tolerance. We conclude that there is genetic heterogeneity in familial GCKD and that
the hypoplastic subtype is a part of the clinical spectrum of the renal cysts and diabetes syndrome that is associated
with HNF-1b mutations.
Familial glomerulocystic kidney disease (GCKD [MIM
137920]) is a rare, inherited renal cystic disorder that is
characterized by autosomal dominant inheritance, var-
iable renal size and renal function, and histology show-
ing cortical glomerular cysts with dilatation of the Bow-
man spaces and primitive glomerular tufts in at least 5%
of the cysts (Bernstein 1993). No gene has been identified
for familial GCKD. The genes for autosomal dominant
polycystic kidney disease, PKD1 (MIM 601313) and
PKD2 (MIM 173910), have been excluded by linkage
studies in Italian (Mesoraca et al. 1996) and US (Sharp
et al. 1997) families.
Glomerulocystic kidneys, as defined by the histolog-
ical features, may be divided into three major categories
(Bernstein 1993): (1) GCKD, which comprises nonsyn-
dromal, inherited, and sporadic forms of cystic kidneys
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in children and adults and includes all subtypes of fa-
milial GCKD; (2) glomerulocystic kidneys as a feature
of inherited malformation syndromes—for example, X-
linked dominant oral-facial-digital syndrome type 1
(Feather et al. 1997) (cysts are inconsistently expressed
in these syndromes); and (3) glomerular cysts in dys-
plastic kidneys, which may be sporadic or syndromal
and may be associated with fetal lower urinary tract
obstruction. The glomerular cysts are minor in com-
parison with the dysplastic features. Glomerular cysts
may be generated experimentally after urinary flow im-
pairment, by ureteric obstruction, in fetal sheep (Attar
et al. 1998).
Mutations in the gene encoding hepatocyte nuclear
factor (HNF)–1b are a cause of renal cystic disease.
HNF-1b is a member of the homeodomain-containing
superfamily of transcription factors. HNF-1b functions
as a homodimer or a heterodimer with the structurally
related HNF-1a (Mendel et al. 1991; Rey-Campos et al.
1991). Heterozygous HNF-1a mutations are the most
common cause of maturity-onset diabetes of the young
(MODY) (Frayling et al. 1997). MODY is a form of
non–insulin-dependent diabetes mellitus characterized
by autosomal dominant inheritance and a young age at
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Figure 1 Pedigrees of two families with HNF-1b mutations.
Roman numerals on left of the figure indicate generation number, and
the numbers below the symbols indicate individuals within that gen-
eration. The HNF-1b genotype of each individual tested is indicated
below the symbol: N,pnormal, Mpmutated allele. Blackened lower
left quadrant p impaired glucose tolerance; blackened lower and up-
per left quadrantsp diabetes; blackened upper right quadrantp renal
cysts; blackened lower right quadrant p renal impairment; diamond
symbol containing a numberp no. of siblings unavailable for testing.
Table 1
Clinical Characteristics of the Probands
CHARACTERISTIC
PROBAND
1 2 3 4
Family BDA395 BDA430 BDA440 BDA298
Mutation None None E101X P159fsdelT
Age at diagnosis of renal disease 30 wk gestation 39 years 9 mo 2 mo
Present age (years) 9 62 34 40
Creatinine (mmol/l)a 80 (39–70) ESRF 164 (35–105) ESRF
Creatinine clearance (ml/min)a 44/1.73 m2 (89–165) NA NA 4 (80–120)
Diabetes No No Yes Yes
Renal size Large kidneys Normal-size kidneys Small kidneys Small kidneys











Other affected family members
and age at diagnosis of renal
disease
Brother, 11 years; mother,
30 years
Son, 13 years; son,
11 years; daughter,
7 years
Sister, 1 mo; mother,
35 years
Son, at birth






Reference Not reported Melnick et al. (1984) Rizzoni et al. (1982) Kaplan et al. (1989)
NOTE.—NA p not available; ESRF p end-stage renal failure.
a Most recently available values, with reference ranges in parentheses.
onset, usually diagnosed at age !25 years (Hattersley
1998). HNF-1b mutations have been reported in four
families with early-onset diabetes (MIM 604284) (Hor-
ikawa et al. 1997; Nishigori et al. 1998; Lindner et al.
1999; Bingham et al. 2000), but they are a rare cause
of MODY (Beards et al. 1998, Weng et al. 2000). Non-
diabetic renal disease was reported in all families, with
renal cysts described in three families. Renal histology
has only been available from two subjects with HNF-
1b mutations. A subject, aged 14 years, from one family
has been shown to have oligomeganephronia with a re-
duced number of glomeruli and hypertrophy of both the
glomeruli and proximal renal tubules (Lindner et al.
1999). Another member of the same family has renal
cystic disease, but histology is not available. A 17-wk
fetus from a second family showed an absence of normal
nephrogenesis, with replacement of the renal paren-
chyma by cysts and occasional cystic glomeruli and
primitive tubules, consistent with cystic renal dysplasia
(Bingham et al. 2000). In the original description of fa-
milial GCKD, one family member was reported as hav-
ing early-onset diabetes (Rizzoni et al. 1982). We there-
fore hypothesized that HNF-1b mutations might be
associated with familial GCKD.
Subjects with familial GCKD were recruited from the
published literature on familial GCKD, including the
Italian family from the original report (Rizzoni et al.
1982). Additional subjects were recruited from adult and
pediatric nephrology clinics in the United Kingdom.
DNA was collected from members of four unrelated
families; the details of the probands are given in table
1. Direct sequencing of the entire promoter and coding
regions of the nine exons and the intron-exon bound-
aries of the HNF-1b gene was performed using an ABI
Prism 377 DNA Sequencer (PE Biosystems). When a
mutation was found, the mutational status was exam-
ined in other available family members.
Two novel heterozygous mutations in the HNF-1b
gene were identified. A nonsense mutation in exon 1,
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E101X, was found in family BDA440 (the Italian family
of the original description). A frameshift mutation in
exon 2, P159fsdelT, with predicted termination at codon
160, was found in family BDA298. The mutations co-
segregate with GCKD in both families (see fig. 1) and
were not present in 60 normal chromosomes.
The clinical characteristics are summarized in table 2
and figure 1. Both families withHNF-1bmutations have
the hypoplastic subtype of familial GCKD. In family
BDA440 (Rizzoni et al. 1982), all three affected subjects
have small kidneys and renal impairment. Intravenous
urogram (IVU) appearances show absent calyces and
irregular, enlarged collecting systems. Renal histology on
subject III:4 has shown cortical cysts with cystic glo-
meruli and glomerular tufts. All three subjects also now
have early-onset diabetes, with an age at diagnosis rang-
ing from 22 to 39 years. In family BDA298 (Kaplan et
al. 1989), both affected subjects have renal impairment
and small kidneys, with cortical cysts visualized on ul-
trasound scanning and calyceal abnormalities on IVU.
Renal histology on II:2 has shown cortical glomerular
cysts and glomerular tufts. II:2 was diagnosed as having
diabetes at age 39 years. After the finding of the mu-
tation, III:1 was found to have impaired glucose toler-
ance on an oral glucose–tolerance test performed at age
17 years. In contrast, the two families with familial
GCKD in which HNF-1b mutations were not found did
not have the hypoplastic subtype of familial GCKD. The
probands from families BDA395 and BDA430 (Melnick
et al. 1984) have large and normal-size kidneys, respec-
tively, and calyceal abnormalities were not reported. A
further difference was that the proband from family
BDA395 had a different histology, since there were col-
lecting-duct as well as glomerular cysts. None of the
families reported have features of any recognized syn-
dromes or evidence of urinary tract obstruction.
This is the first description of an etiological gene for
familial GCKD. Our results suggest that there is genetic
heterogeneity within familial GCKD. The two families
with HNF-1b mutations that we describe have been de-
scribed elsewhere as having the hypoplastic subtype of
familial GCKD (Rizzoni et al. 1982; Kaplan et al. 1989).
Both families have the clinical features of small kidneys
and abnormal calyces and papillae seen in this subtype.
We were unable to obtain DNA from a third published
French pedigree (Rizzoni et al. 1982). Both familieswith-
out HNF-1b mutations have nonhypoplastic familial
GCKD, since they have large or normal-size kidneys and
normal calyces and papillae. This suggests thatHNF-1b
mutations are an important cause of the hypoplastic
subtype but may not have an etiological role in non-
hypoplastic familial GCKD. A further gene or genes are
likely to be identified in GCKD. The role that HNF-1b
mutations may have in the other categories of GCKD is
currently unknown and warrants investigation, espe-
cially in sporadic isolated GCKD, because a spontaneous
HNF-1b mutation has been described (Bingham et al.
2000).
In addition to hypoplastic GCKD, the other charac-
teristic clinical feature of the two families with HNF-1b
mutations is early-onset diabetes, which was not seen in
the two families without mutations. All three affected
subjects in family BDA440 have early-onset diabetes. In
the original report on this family, diabetes was only de-
scribed in one subject but has subsequently developed
in her two daughters. This family, with an autoso-
mal dominant inheritance of diabetes and two subjects
diagnosed at age !25 years, would meet the diagnostic
criteria for MODY (Hattersley 1998). In family
BDA298, the mother developed diabetes at age 39 years,
and we have established, after identification of anHNF-
1b mutation, that her son has impaired glucose tolerance
on an oral glucose tolerance test at age 17 years. This
family does not, at present, reach diagnostic criteria for
MODY. In these families, the diabetes has presented
years or decades after the renal disease, which explains
why this was not previously recognized as a clinical char-
acteristic of their familial hypoplastic GCKD.
The nonsense and frameshift mutations we describe
in families with hypoplastic GCKD are predicted to re-
sult in truncated proteins, with the loss of part of the
DNA-binding region of the protein and all of the tran-
scription-activation domain. They are likely to be
loss-of-function mutations. The previously described
R137-K161del mutation, which resulted in oligomega-
nephronia and abnormal uterine and vaginal develop-
ment, was shown in functional studies to be a loss-of-
function mutation (Lindner et al. 1999). However, the
resulting in-frame deletion leads to a loss of the pseudo-
POU domain, which is implicated in giving specificity
to DNA binding, but the transactivation domain was
preserved. Lindner and colleagues suggest that the gen-
ital abnormalities may result from the mutant transcrip-
tion factor, with its retained transactivation domain in-
teracting with other transcription factors or basal
transcription activity and altering genital development
(Lindner et al. 1999). In contrast, the frameshift mu-
tation P328L329fsdelCCTCT, present in the fetus with
cystic renal dysplasia, has been shown to be a gain-of-
function mutation (Wild et al. 2000). Overexpression of
this mutation in the Xenopus embryo leads to defective
development and agenesis of the pronephros, the first
kidney form of amphibians (Wild et al. 2000).
HNF-1b is known to be expressed from the earliest
inductory phases of kidney development in the rat. In
the newborn rat kidney, HNF-1b transcripts are found
in the proximal and distal convoluted tubules, the loop
of Henle, and the collecting ducts (Lazzaro et al. 1992).
Renal abnormalities have been detected on fetal ultra-
sound scanning in subjects from the reported families
Table 2
Clinical Characteristics of the Affected Subjects
CHARACTERISTIC
SUBJECT
1 2 3 4 5
Family BDA440 BDA440 BDA440 BDA298 BDA298
Subject III 3 III 4 II 2 III 1 II 2
Mutation E101X E101X E101X P159fsdelT P159fsdelT
Age at diagnosis of renal
disease 9 mo 1 mo 35 y At birth 2 mo
Present age (y) 34 29 60 18 40
Blood pressure (mmHg) 150/90 120/80 120/80 90/50 110/50
Creatinine (mmol/l)a 164 (35–105) 191 (35–105) 282 (35–105) 193 (45–120) ESRF
Creatinine clearance (ml/min)a NA NA NA 23 (90–130) 4 (80–120)
24-hour urine protein (g/24 hr)a No proteinuria No proteinuria 1.8 (.01–.14) .18 (.01–.14) .32 (.01–.14)
IVU Small kidneys; bilateral
enlarged pelvis and
absent calyces






Abnormal calyces Small kidneys with abnor-
mal calyces
Renal ultrasound NA NA NA Small kidneys with cysts Small kidneys with cysts
Renal histology NA Cortical cysts; cystic glomer-
uli with glomerular tufts




Age at diagnosis of diabetes
(years) 22 23 39 17b 39
Treatment for diabetes Insulin Insulin Insulin None (not diabetic) Oral hypoglycemic agents
Other features … Prognathism … Learning difficulties Prognathism; pyloric stenosis
NOTE.—NA p not available; ESRF p end-stage renal failure.
a Most recently available values, with reference ranges in parentheses.
b Impaired glucose tolerance.
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withHNF-1b mutations (Nishigori et al. 1998; Bingham
et al. 2000). Cystic changes associated with HNF-1b
mutations occur early in fetal development, supporting
a major role for HNF-1b in human kidney development.
In the studies on rat kidney, HNF-1b was not found to
be expressed in the glomeruli (Lazzaro 1992). In view
of our finding of HNF-1b mutations in cases of GCKD,
it is interesting to investigate whether HNF-1b is ex-
pressed in the glomeruli in the human kidney. Alterna-
tively, the glomerular cysts may result from an early
disruption in nephron development.
This report describes the fifth and sixth families in
which an HNF-1b mutation has been found that cose-
gregates with diabetes and/or renal disease. Early-onset
diabetes is a constant feature of all families, but the non-
diabetic renal manifestations are variable (Horikawa et
al. 1997; Nishigori et al. 1998; Lindner et al. 1999; Bing-
ham et al. 2000). Three separate histologies have been
described—oligomeganephronia, cystic dysplasia, and hy-
poplastic GCKD. It is likely that all these renal phenotypes
are manifestations of abnormal nephron development.
The most constant clinical feature is the presence of renal
cysts, which have been seen in members of five of the six
families described. In the sixth family, there was no de-
scription of renal appearance or histology (Horikawa et
al.1997). We therefore propose that HNF-1b mutations
frequently result in a clinical syndrome characterized by
renal cysts and diabetes (RCAD). The recognition of this
autosomal dominantly inherited syndrome will assist the
identification of patients in whomHNF-1bmutation test-
ing is desirable.
We conclude that HNF-1b gene mutations are asso-
ciated with the hypoplastic subtype of familial GCKD.
We have established that there is genetic heterogeneity
in familial GCKD, which reflects clinical heterogeneity.
In the families in which we have identified HNF-1b mu-
tations, affected subjects have hypoplastic GCKD and
early-onset diabetes. This is the third renal histology to
be reported in association with HNF-1b mutations, and
it reinforces the variability in the renal phenotype as-
sociated with these mutations. All renal phenotypes as-
sociated with HNF-1b mutations are likely to represent
abnormal nephron development. These observations al-
low a further extension of the molecular genetic clas-
sification of renal cystic disease that cuts across previous
classification by clinical or histological criteria. Familial
hypoplastic GCKD forms part of the clinical spec-
trum of the RCAD syndrome associated with HNF-1b
mutations.
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